Ana Belen Ibarz Pavon

Ana Belen Ibarz Pavon

Auto-generated profile, based on publicly available information

Ana Belen Ibarz Pavon

FIND, Geneva, Switzerland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2014 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
CMCarla Muñoz-Antoli
Carla Muñoz-Antoli
APA. Pavón
A. Pavón
AMAntonio Marcilla
Antonio Marcilla
Rafael ToledoRafael Toledo
Rafael Toledo
JEJ Guillermo Esteban
J Guillermo Esteban
The present study was carried out to assess the prevalence of intestinal parasite infections among children in Department of Rio San Juan (Nicaragua), to explore the extent of polyparasitism, and to identify the risk factors that might favour transmission of these parasites. A coprological study of single stool specimen, collected at random from 382 children (167 boys and 215 girls) aged 2-15 years from two municipalities, and a questionnaire, concerning demographic and epidemiological data on sanitary and behavioural habits, was filled in to identify risk factors. About 93% of the children presented infection. Blastocystis hominis, the most frequently protozoa, and Trichuris trichiura, Ascaris lumbricoides and hookworm, the most prevalent helminths. Polyparasitism (85.4%[326/382]), with the highest percentages detected in females (p=0.001), in the 6-11 year age group (p<0.001) and having a rural background (p<0.001). A firm relationship between any parasite and age (OR=1.2, p=0.036) and rural background (OR=0.3, p=0.027) was detected. Living in rural areas and drinking river water were also positively associated with each of the STH species detected, and walking barefoot was also associated with hookworm infection. Government efforts should be focused on controlling the risk factors associated with these enteroparasites, with health education programmes in rural areas of Nicaragua.

16 June 2026 in BMJ Global Health
Verified
Journal Article
Open access
BGBirgitta Gleeson
Birgitta Gleeson
BBBenjamin Blumel
Benjamin Blumel
APAna Belen Ibarz Pavon
Ana Belen Ibarz Pavon
RKRebecca Kirby
Rebecca Kirby
CHCannon Hansen
Cannon Hansen
KPKara Palamounta
Kara Palamounta
Neonatal sepsis is a leading cause of infant morbidity and mortality in low- and middle-income countries (LMICs), yet despite this, progress in the development and implementation of effective diagnostics has been limited. Current diagnostic methods rely on clinical assessments of nonspecific signs and symptoms, limited laboratory testing and technologies that are inaccessible, unaffordable or unsuitable for resource-constrained settings. There is an urgent need for reliable, affordable and context-appropriate point-of-care diagnostics. This analysis synthesises evidence across current and emerging diagnostic strategies for neonatal sepsis, including clinical algorithms, host-response biomarkers, haematological parameters, continuous monitoring and artificial intelligence-based digital platforms. We assess their performance, operational feasibility in LMICs and alignment with the WHO Target Product Profile (TPP) for neonatal sepsis, including requirements for highly sensitive triage, feasibility in non-hospital settings and suitability for use at the point of care in LMICs. We identified promising existing technologies and emerging approaches that could be used to address the challenges of diagnosing neonatal sepsis in LMICs. These include host-response biomarkers that offer greater accuracy than those currently used, as well as affordable technologies that can improve current predictive algorithms. Taken together, these findings support a move towards integrated, TPP-aligned diagnostic strategies that combine affordable point-of-care testing, routine clinical data and digital decision support to improve early detection, rationalise antibiotic use and reduce neonatal mortality.

15 September 2025 in Gates Open Research
Verified
Journal Article
Open access
PDF file
APAna Belen Ibarz Pavon
Ana Belen Ibarz Pavon
JCJohn Clemens
John Clemens
ACAlejandro Craviotto
Alejandro Craviotto
JCJohn A. Crump
John A. Crump
DGDenise O. Garrett
Denise O. Garrett
AWAnnelies Wilder-Smith
Annelies Wilder-Smith
In 2021, Salmonella Paratyphi A caused >2 million illnesses, resulting in >14,000 deaths, most of which occurred among children under 5 years of age in socioeconomically deprived populations. Both typhoid fever and paratyphoid fever occur in such areas, but paratyphoid fever is currently concentrated in South Asia. Typhoid conjugate vaccines are recommended for the control of enteric fever in typhoid-endemic settings; however, there are increasing demands for the development of vaccines that can address enteric fever more broadly by including protection against paratyphoid fever. The WHO preferred product characteristics (PPC) and a research and development (R&D) technology roadmap are normative documents developed with the guidance and contribution of a multidisciplinary expert group following a standard methodological framework. In this paper, we summarize the PPC and R&D roadmap presenting the key attributes for a bivalent Salmonella enterica serovar Typhi and Paratyphi A vaccine, and discuss the identified key research and data gaps needed to optimize vaccine value and to inform public health and policy decisions, with a particular focus in paratyphoid and enteric fever endemic countries.